| |
| |
|
| Insider
Information: |
Cpmg Inc |
| Relationship: |
|
| City: |
Dallas |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
113 |
|
|
Indirect Shares
|
5,557,937 |
|
|
| Direct
Value |
$19,477 |
|
|
|
Indirect Value
|
$525,901,870 |
|
|
| Total
Shares |
5,558,050 |
|
|
| Total
Value |
$525,921,346 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 125.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genitope Corp |
GTOP |
Former 10% Owner |
2008-12-10 |
0 |
2008-12-10 |
0 |
Premium* |
|
|
Reata Pharmaceuticals Inc |
RETA |
|
2020-12-23 |
113 |
2020-12-23 |
2,896,788 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
|
|
0 |
2021-10-15 |
2,661,149 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-08-18 |
4 |
B |
$17.32 |
$1,828,651 |
I/I |
105,562 |
288,102 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-14 |
4 |
B |
$24.65 |
$1,929,698 |
I/I |
78,275 |
431,155 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-06-30 |
4 |
B |
$19.75 |
$1,975,110 |
I/I |
100,000 |
88,920 |
0.01 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
|
• • • |
2020-07-17 |
4 |
B |
$1.25 |
$2,225,000 |
I/I |
1,780,000 |
1,707,208 |
0.01 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-08-17 |
4 |
B |
$17.26 |
$2,486,816 |
I/I |
144,058 |
253,972 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-13 |
4 |
B |
$23.98 |
$3,028,708 |
I/I |
121,725 |
393,663 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2018-12-11 |
4 |
B |
$60.07 |
$3,172,337 |
I/I |
52,809 |
109,408 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-06-01 |
4 |
B |
$11.43 |
$3,194,224 |
I/I |
251,553 |
252,706 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2018-12-10 |
4 |
B |
$57.93 |
$3,326,566 |
I/I |
56,599 |
56,599 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-12-16 |
4 |
B |
$22.99 |
$3,787,820 |
I/I |
164,753 |
332,230 |
0.01 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
|
• • • |
2021-10-15 |
4 |
B |
$7.75 |
$5,300,000 |
I/I |
683,871 |
2,151,209 |
0.01 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2019-11-18 |
4 |
B |
$183.00 |
$7,359,894 |
I/I |
40,218 |
5,464 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-06-01 |
4/A |
B |
$11.00 |
$8,822,000 |
I/I |
802,000 |
99,922 |
2.64 |
- |
|
38 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
